Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Vor Biopharma

Vor Bio Reports First Quarter 2023 Financial Results and Provides Company Update
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
Vor Bio to Participate in Upcoming Investor Conferences
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
Vor Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
Vor Bio to Participate in Upcoming Investor Conferences
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
First AML Patient Transplanted with Vor Bio’s Trem-cel Demonstrated Durable Engraftment through Multiple Mylotarg™ Cycles at Initial Dose Level
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
Vor Bio to Present Clinical Data from First Patient Treated with Trem-cel at 2023 Tandem Meetings
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
Vor Bio to Present at B. Riley Securities’ 3rd Annual Oncology Conference
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
First AML Patient Successfully Transplanted with Vor Bio’s Investigational Trem-cel (VOR33) and Tolerated Mylotarg™
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
Vor Bio to Participate in Upcoming Investor Conferences
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
Vor Bio Reports Third Quarter 2022 Financial Results and Provides Company Update
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
Vor Bio to Participate in Upcoming Investor Conferences
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
Vor Bio Appoints Eyal C. Attar, M.D. as Chief Medical Officer
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
Vor Bio Demonstrates Potential of Base and Sequential Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
Vor Bio Initiates In-house Clinical Manufacturing at Cambridge, MA Headquarters
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.